Magnetic resonance imaging or expert ultrasound in preoperative local staging of patients with early-stage cervical cancer: final results of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)

Kocián, RomanSiegler, KathrinKlát, JaroslavBenešová, KláraPaderno, MariachiaraLonkhuijzen, Luc VanChaloupková, BarboraPilka, RadovanMichal, MartinKašcák, PeterKridelka, FrédéricPakiž, MajaSnyman, Leon CorneliusBarahona, MarcSawicki, SamborBlecharz, PawelRedecha, MikulášTóth, RóbertCibula, DavidKöhler, Christhardt2025-03-312025-03-312023-09-011048-891Xhttps://hdl.handle.net/2445/220129Comunicació/presentació a: 24th European Congress on Gynaecological Oncology, European Society of Gynaecological Oncology, Istanbul, 28 setembre -1 octubre 2023SENTIX is a prospective, single-arm, international study of sentinel lymph node (SLN) biopsy without pelvic lymph node dissection (PLND) in patients with early-stage cervical cancer.2 p.application/pdfengcc-by-nc-nd (c) IGCS, ESGO, 2023http://creativecommons.org/licenses/by-nc-nd/3.0/es/Càncer de coll uteríImatges per ressonància magnèticaCervix cancerMagnetic resonance imagingMagnetic resonance imaging or expert ultrasound in preoperative local staging of patients with early-stage cervical cancer: final results of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)info:eu-repo/semantics/conferenceObject2024-10-16info:eu-repo/semantics/openAccess